Down-regulated CD5L was also shown to be negatively with the HCC-A pathological stage while up-regulated CSAG3 and CSMD1 were shown to be positively correlated with the HCC-A pathological grade (p < 0.05). This evidence concerns the gene CD5L and hepatocellular carcinoma.